Profile data is unavailable for this security.
About the company
Shanghai Aohua Photoelectricity Endoscope Co Ltd is a China-based company primarily engaged in the research and development, production, and sales of electronic endoscopic equipment and endoscopic diagnostic and surgical consumables. The Company’s endoscopic equipment includes endoscopy main units (with image processors and light sources), endoscope bodies, and peripheral endoscopic devices. The Company’s endoscopic diagnostic and surgical consumables mainly include non-vascular stents and basic consumables. The Company’s products are mainly applied in clinical departments such as gastroenterology, respiratory, otorhinolaryngology, gynecology, and emergency medicine. The Company conducts its business in the domestic and overseas markets.
- Revenue in CNY (TTM)671.62m
- Net income in CNY-72.38m
- Incorporated1994
- Employees1.22k
- LocationShanghai Aohua Photoelectricity Endoscope Co LtdNo.660 Shengang Road, Songjiang DistrictSHANGHAI 201108ChinaCHN
- Phone+86 2 154303731
- Fax+86 2 167681020
- Websitehttps://www.aohua.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hangzhou Ags Medtech Co Ltd | 668.70m | 272.95m | 4.98bn | 744.00 | 18.19 | 2.00 | -- | 7.44 | 3.37 | 3.37 | 8.25 | 30.67 | 0.2673 | 3.31 | 11.94 | 898,793.60 | 10.91 | -- | 11.39 | -- | 69.67 | -- | 40.82 | -- | 18.27 | -- | 0.001 | -- | 25.14 | -- | 35.06 | -- | -- | -- |
| Zhejiang Orient Gene Biotech Co Ltd | 842.11m | -479.50m | 5.01bn | 2.28k | -- | 0.787 | -- | 5.94 | -2.48 | -2.48 | 4.37 | 31.55 | 0.107 | 1.44 | 3.39 | 369,997.60 | -6.68 | 21.19 | -7.77 | 26.74 | 34.88 | 58.52 | -62.43 | 32.42 | 3.86 | -- | 0.0462 | 24.78 | 0.946 | 17.65 | -33.06 | -- | 138.80 | -- |
| Assure Tech (Hangzhou) Co Ltd | 462.72m | 120.87m | 5.04bn | 741.00 | 41.72 | 0.9768 | -- | 10.90 | 0.9511 | 0.9511 | 3.64 | 40.62 | 0.0809 | 2.22 | 2.17 | 624,449.30 | 2.11 | 23.69 | 2.30 | 28.01 | 30.32 | 64.61 | 26.11 | 47.65 | 11.28 | -- | 0.0012 | 18.78 | 7.42 | 20.85 | 35.85 | 28.69 | 63.16 | -- |
| Nanjing Vishee Medical Technology Co Ltd | 433.83m | 125.95m | 5.42bn | 639.00 | 43.03 | 3.27 | -- | 12.49 | 1.32 | 1.32 | 4.53 | 17.31 | 0.2411 | 4.00 | 14.42 | 678,922.30 | 7.00 | 8.39 | 7.63 | 9.20 | 61.24 | 71.62 | 29.03 | 32.76 | 6.54 | -- | 0.0182 | 59.13 | -13.45 | 4.64 | -25.16 | 0.4474 | 39.73 | -- |
| Hangzhou Biotest Biotech Co Ltd | 478.69m | 102.57m | 5.44bn | 603.00 | 52.28 | 2.33 | -- | 11.36 | 0.6964 | 0.6964 | 3.06 | 15.66 | 0.1913 | 3.20 | 5.70 | 793,854.10 | 4.02 | 23.63 | 4.25 | 26.20 | 50.57 | 56.59 | 21.00 | 41.47 | 13.08 | -- | 0.00008 | 34.42 | 26.53 | 21.78 | 59.01 | 43.12 | 44.08 | -- |
| SWS Hemodialysis Care Co Ltd | 733.59m | 113.43m | 5.52bn | 1.10k | 48.84 | 3.13 | -- | 7.53 | 0.3538 | 0.3538 | 2.29 | 5.52 | 0.3577 | 2.80 | 6.23 | 665,688.20 | 5.23 | 5.68 | 5.83 | 6.54 | 45.71 | 45.79 | 14.61 | 16.06 | 5.25 | -- | 0.0014 | 28.46 | -17.80 | 31.86 | -63.55 | -- | 24.70 | -- |
| Shanghai Aohua Phtlctrcty Endscp Co Ltd | 671.62m | -72.38m | 5.76bn | 1.22k | -- | 4.62 | -- | 8.57 | -0.5475 | -0.5475 | 5.10 | 9.25 | 0.3834 | 1.02 | 2.29 | 552,775.60 | -4.14 | 3.01 | -5.15 | 3.34 | 61.79 | 68.86 | -10.80 | 7.52 | 1.57 | -- | 0.2086 | 43.30 | 10.54 | 20.28 | -63.68 | -16.86 | 23.29 | -- |
| Qingdao NovelBeam Technology Co Ltd | 571.80m | 174.33m | 5.85bn | 841.00 | 33.62 | 4.44 | -- | 10.23 | 1.45 | 1.45 | 4.76 | 10.99 | 0.3817 | 0.9932 | 5.67 | 679,901.10 | 11.39 | 12.70 | 12.61 | 14.11 | 64.34 | 63.15 | 29.84 | 33.96 | 3.43 | 51.04 | 0.1058 | 40.95 | -5.90 | 11.86 | -7.11 | 13.48 | 13.44 | -- |
| Jiangsu Bioperfectus Technologies Co Ltd | 339.03m | -25.96m | 5.88bn | 592.00 | -- | 1.98 | -- | 17.36 | -0.3096 | -0.3096 | 4.04 | 35.38 | 0.0903 | 1.85 | 6.13 | 572,683.70 | -0.6919 | 20.36 | -0.796 | 24.55 | 58.22 | 62.71 | -7.66 | 31.89 | 3.22 | -- | 0.1329 | 28.76 | -13.29 | 3.90 | 99.46 | -- | -9.88 | -- |
| Shenzhen Lifotronic Technology Co Ltd | 1.05bn | 251.02m | 5.93bn | 1.67k | 23.41 | 2.82 | -- | 5.62 | 0.5907 | 0.5907 | 2.47 | 4.90 | 0.3855 | 2.51 | 5.74 | 631,202.60 | 8.98 | 14.03 | 12.10 | 17.34 | 61.03 | 62.46 | 23.30 | 27.25 | 3.00 | -- | 0.1406 | 39.01 | 0.2024 | 22.12 | 5.12 | 27.99 | -1.63 | 18.64 |
| Holder | Shares | % Held |
|---|---|---|
| China Universal Asset Management Co., Ltd.as of 30 Jun 2025 | 12.84m | 13.94% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 7.86m | 8.53% |
| ICBC UBS Asset Management Co. Ltd.as of 30 Jun 2025 | 4.14m | 4.50% |
| GF Fund Management Co., Ltd.as of 30 Jun 2025 | 2.36m | 2.56% |
| Bosera Asset Management Co., Ltd.as of 30 Jun 2025 | 2.17m | 2.35% |
| Golden Trust Sinopac Fund Management Co., Ltd.as of 30 Jun 2025 | 2.16m | 2.34% |
| Galaxy Asset Management Co., Ltd.as of 30 Jun 2025 | 1.66m | 1.81% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 1.42m | 1.54% |
| Zhong Ou Asset Management Co., Ltdas of 30 Jun 2025 | 1.34m | 1.45% |
| Harfor Fund Management Co., Ltd.as of 30 Jun 2025 | 1.30m | 1.41% |
